Provided by Tiger Fintech (Singapore) Pte. Ltd.

Stoke Therapeutics, Inc.

11.52
-0.2950-2.50%
Volume:152.33K
Turnover:1.76M
Market Cap:628.68M
PE:13.13
High:11.90
Open:11.78
Low:11.35
Close:11.81
Loading ...

Stoke Therapeutics Inc. Files Initial Statement of Beneficial Ownership for Chief Patient Officer Jason Hoitt

Reuters
·
24 Jun

Stoke Therapeutics Announces New Stock Option Inducement Grants for Employees Under Nasdaq Rule

Reuters
·
18 Jun

Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
18 Jun

Skorpios Trust Reports Disposal of Common Shares of Stoke Therapeutics Inc

Reuters
·
07 Jun

Chief Medical Officer Barry Ticho Reports Disposal of Common Shares of Stoke Therapeutics Inc

Reuters
·
05 Jun

Stoke Therapeutics Inc. Conducted Annual Meeting of Stockholders

Reuters
·
05 Jun

Stoke Therapeutics Inc. to Present at Jefferies Global Healthcare Conference

Reuters
·
29 May

Stoke Therapeutics, Inc. : H.c. Wainwright Cuts Target Price to $35 From $47

THOMSON REUTERS
·
14 May

Stoke Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
13 May

BRIEF-Stoke Therapeutics Q1 Operating Income USD 111.24 Million

Reuters
·
13 May

Stoke Therapeutics Q1 EPS $1.90 Beats $(0.42) Estimate, Sales $158.57M Beat $7.61M Estimate

Benzinga
·
13 May

Stoke Therapeutics Initiates Phase 3 Trial for Zorevunersen, Aiming to Launch First Disease-Modifying Treatment for Dravet Syndrome by Mid-2028

Reuters
·
13 May

Stoke Therapeutics Inc. Reports Q1 2025 Results: No Significant Changes in Sales, Revenue, or EPS Noted

Reuters
·
13 May

Analysts Have Conflicting Sentiments on These Healthcare Companies: Stoke Therapeutics (STOK), Novavax (NVAX) and McKesson (MCK)

TIPRANKS
·
09 May

Stoke Therapeutics Inc expected to post a loss of 43 cents a share - Earnings Preview

Reuters
·
02 May

CG Oncology, Inc. (CGON) May Report Negative Earnings: Know the Trend Ahead of Q1 Release

Zacks
·
01 May

Is There An Opportunity With Stoke Therapeutics, Inc.'s (NASDAQ:STOK) 49% Undervaluation?

Simply Wall St.
·
24 Apr

Stoke Therapeutics (STOK) Upgraded to Buy: What Does It Mean for the Stock?

Zacks
·
23 Apr

Stoke Therapeutics remains significantly undervalued, says Canaccord

TIPRANKS
·
31 Mar

Earnings Beat: Stoke Therapeutics, Inc. (NASDAQ:STOK) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts

Simply Wall St.
·
22 Mar